Quantcast

Latest Organofluorides Stories

2014-01-21 23:29:42

The DrugRisk Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Philadephia, PA (PRWEB) January 21, 2014 The prescription drug safety advocates at DrugRisk.com have added new information to the site for patients and families of those who have taken the antipsychotic drug Risperdal. Court records show lawsuits alleging the drug caused abnormal breast growth have now spread to federal court*....

2014-01-18 12:20:20

SAN FRANCISCO, Jan. 18, 2014 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) presented favorable data today from a Phase 1 study of etirinotecan pegol (EP, NKTR-102) in combination with 5-fluorouracil (5-FU)/Leucovorin (LV) in patients with advanced cancer. NKTR-102 is the first long-acting topoisomerase I-inhibitor designed to concentrate in tumor tissue, provide sustained tumor suppression throughout the entire chemotherapy cycle, and to reduce the peak exposures that are associated...

2014-01-16 23:00:27

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today. Philadelphia, PA (PRWEB) January 16, 2014 The medication safety advocates at DrugNews.net are announcing updated information for patients and parents of those who have taken the antipsychotic drug Risperdal. Court documents show patients alleging the drug caused abnormal breast growth have asked a judge to unseal data from Risperdal...

2014-01-16 14:22:49

University of Leicester researchers deploy 'precision medicine' to successfully target advanced form of leukaemia with skin cancer drug A team of scientists from the University of Leicester has demonstrated a novel treatment for Hairy Cell Leukaemia (HCL), a rare type of blood cancer, using a drug administered to combat skin cancer. The research, which is published today (Thursday 16 January) in the New England Journal of Medicine, indicates Vemurafenib, a BRAF inhibitor that has been...

2014-01-15 23:29:28

Insomnia Free 4 Life designed by John Parkin is the latest program that covers natural and safe remedies to cure their insomnia easily without any medication. A full review on the site HealthReviewCenter.com indicates if Insomnia Free 4 Life is worth buying. Seattle, Wa (PRWEB) January 15, 2014 Insomnia or sleeplessness is a sleep disorder in which there is an inability to fall asleep or to stay asleep as long as desired. Insomnia Free 4 Life is a new solution for those people who want to...

2014-01-14 16:25:28

DUBLIN, Jan. 14, 2014 /PRNewswire/ -- Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval for its abbreviated new drug application ("ANDA") for fluocinonide cream 0.1%, the generic equivalent to Vanos® Cream 0.1%. Perrigo was awarded 180-days of generic drug exclusivity as it was the first company to submit an ANDA containing a paragraph IV certification. Perrigo had previously resolved litigation with the brand and has commenced shipment of the...

2014-01-14 08:29:36

SAN FRANCISCO, Jan. 14, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) announced today that the Independent Data Monitoring Committee (DMC) created to provide safety oversight for the Company's pivotal clinical study for etirinotecan pegol (NKTR-102) has recommended continuation of the BEACON phase 3 trial, based upon the completion of a planned interim efficacy analysis in accordance with the DMC charter. The BEACON trial is evaluating NKTR-102 versus an agent of physician's...

2014-01-13 08:30:09

FLORHAM PARK, N.J., Jan. 13, 2014 /PRNewswire/ -- Shionogi Inc. today announced that it has entered into an exclusive, multi-year agreement with Noven Pharmaceuticals to co-promote Brisdelle(TM) (paroxetine) capsules, 7.5 mg, the first and only non-hormonal prescription drug approved for the treatment of moderate to severe hot flashes associated with menopause. Under the terms of the agreement, Shionogi will promote Brisdelle, along with Osphena(TM) (ospemifene), its non-estrogen oral...

2014-01-13 08:29:50

Co-Promotion to Extend Physician Awareness of the First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Menopausal Hot Flashes MIAMI and NEW YORK, Jan. 13, 2014 /PRNewswire/ -- Noven Pharmaceuticals, Inc. today announced that it has entered into an agreement with Shionogi Inc. to co-promote Brisdelle(TM) (paroxetine) capsules, 7.5 mg. The agreement will help extend physician awareness of the first and only FDA-approved, non-hormonal treatment for moderate to severe...

2014-01-10 12:22:26

WASHINGTON, Jan. 10, 2014 /PRNewswire-USNewswire/ -- Environmental Investigation Agency (EIA): In a major win for the climate, the Verified Carbon Standard (VCS), the world's leading voluntary greenhouse gas program, has announced that it will no longer approve or accept for consideration new methodologies and projects relating to HFC-23, acknowledging progress under the Montreal Protocol, G-20 and other bilateral government discussions on the international regulation of hydrofluorocarbons...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related